4-bromobicyclo[2.2.1]heptane-1-carboxylic acid

Catalog No.: 
ACAJMP965
CAS No.: 
15448-85-8
Molecular Formula: 
C8H11BrO2
Molecular Weight: 
219.08
4-bromobicyclo[2.2.1]heptane-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$425.00In stockInquiry
250mg95%$681.00In stockInquiry
500mg95%$1134.00In stockInquiry
1g95%$1699.00In stockInquiry
5g95%$5096.00In stockInquiry
10g95%$8510.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-bromobicyclo[2.2.1]heptane-1-carboxylic acid
IUPAC Name4-bromobicyclo[2.2.1]heptane-1-carboxylic acid
MDL No.MFCD24481116
Molecular FormulaC8H11BrO2
Molecular Weight219.08
SMILESO=C(C1(C2)CCC2(Br)CC1)O
InChI KeyDKZHMCMRZOJEHS-UHFFFAOYSA-N
Synonym4-bromobicyclo[2.2.1]heptane-1-carboxylic acid | 15448-85-8 | MFCD24481116 | BS-43206 | CS-0058476 | 4-bromobicyclo[2.2.1]heptane-1-carboxylicacid | P18594
CAS No.15448-85-8
PubChem CID14611217

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAJMP965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCJUP053 route compound structure diagram
    ACCJUP05315448-84-7In Stock
  2. Then
  3. ACAJMP965 route product structure diagram
    ACAJMP96515448-85-8In Stock
Inquiry

2. ACAJMP965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAJMP965 route product structure diagram
    ACAJMP96515448-85-8In Stock
Inquiry

3. ACAJMP965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAJMP965 route product structure diagram
    ACAJMP96515448-85-8In Stock
Inquiry

Comments (0)